Medgend Icon

Ledgend of Medicine







discontinued


Anti

What are blood thinners?

Blood thinners are medicines that prevent blood clots from forming. They do not break up clots that you already have. But they can stop those clots from getting bigger. It's important to treat blood clots, because clots in your blood vessels and heart can cause heart attacks, strokes, and blockages.

Who needs blood thinners?

You may need a blood thinner if you have:

  • Certain heart or blood vessel diseases
  • An abnormal heart rhythm called atrial fibrillation
  • A heart valve replacement
  • A risk of blood clots after surgery
  • Congenital heart defects
What are the different types of blood thinners?

There are different types of blood thinners:

  • Anticoagulants, such as heparin or warfarin (also called Coumadin), slow down your body's process of making clots.
  • Antiplatelets, such as aspirin and clopidogrel, prevent blood cells called platelets from clumping together to form a clot. Antiplatelets are mainly taken by people who have had a heart attack or stroke.
How can I take blood thinners safely?

When you take a blood thinner, follow the directions carefully. Blood thinners may interact with certain foods, medicines, vitamins, and alcohol. Make sure that your health care provider knows all of the medicines and supplements you are using.

You may need regular blood tests to check how well your blood is clotting. It is important to make sure that you're taking enough medicine to prevent clots, but not so much that it causes bleeding.

What are the side effects of blood thinners?

Bleeding is the most common side effect of blood thinners. They can also cause an upset stomach, nausea, and diarrhea.

Other possible side effects can depend on which type of blood thinner that you are taking.

Call your provider if you have any sign of serious bleeding, such as:

  • Menstrual bleeding that is much heavier than normal
  • Red or brown urine
  • Bowel movements that are red or black
  • Bleeding from the gums or nose that does not stop quickly
  • Vomit that is brown or bright red
  • Coughing up something red
  • Severe pain, such as a headache or stomachache
  • Unusual bruising
  • A cut that does not stop bleeding
  • A serious fall or bump on the head
  • Dizziness or weakness

Anti FDA Approved Drugs

ADASUVE [LoxapineC18H18ClN3O]
RX
-
10mg (inhalation powder)
Alexza PharmsDec 21, 2012
  • Adasuve is a typical antipsychotic indicated for the acute treatment of agitation associated with schizophrenia or bipolar i disorder in adults.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ANTIZOL [FomepizoleC4H6N2]
RX
-
1.5gm/1.5ml (1gm/ml) (injection injectable)
Par Pharm IncDec 4, 1997
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CABOMETYX [Cabozantinib S-malateC28H24FN3O5C4H6O5]
RX
-
eq 20mg base (oral tablet)
eq 40mg base (oral tablet)
eq 60mg base (oral tablet)
Exelixis IncApr 25, 2016
  • Treatment of renal cell carcinoma.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CALDOLOR [IbuprofenC13H18O2]
RX
-
800mg/8ml (100mg/ml) (intravenous solution)
Cumberland PharmsJun 11, 2009
  • Management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics in a critically ill patient with intravenous ibuprofen in need thereof.
  • Management of mild to moderate pain, management of moderate to severe pain as an adjunct to opioid analgesics, reduction in fever through anti-inflammatory, analgesic, and antipyretic activity.
  • Management of mild to moderate pain, management of moderate to severe pain as an adnunct to opioid analgesics, reduction in fever through anti inflammatory, analgesic, and antipyretic activity.
  • Methods of treating pain, inflammation and/or fever in a critically ill patient with intravenous ibuprofen in need thereof.
  • Methods of treating pain, inflammation and/or fever with intravenous ibuprofen such that mean arterial blood pressure does not increase the dosage interval.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CANTIL [Mepenzolate BromideC21H26NO3Br]
RX
-
25mg (oral tablet)
Sanofi Aventis UsApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CEFPODOXIME PROXETIL [Cefpodoxime ProxetilC21H27N5O9S2]
RX
-
eq 100mg base (oral tablet)
eq 100mg base/5ml (oral for suspension)
eq 200mg base (oral tablet)
eq 50mg base/5ml (oral for suspension)
Aurobindo PharmaJun 11, 2007
Orchid HlthcareNov 14, 2007
SandozMay 28, 2008
Aurobindo Pharma LtdJun 8, 2007
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CHANTIX [Varenicline TartrateC13H13N3C4H6O6]
RX
-
eq 0.5mg base (oral tablet)
eq 1mg base (oral tablet)
Pfizer IncMay 10, 2006
  • Aid to smoking cessation.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CHLORAPREP ONE-STEP [Chlorhexidine GluconateC22H30Cl2N102C6H12O7 : Isopropyl AlcoholC3H8O]
OTC
-
2% : 70% (10.5ml) (topical sponge)
2% : 70% (26ml) (topical sponge)
2% : 70% (3ml) (topical sponge)
Becton Dickinson CoAug 20, 2003
  • Use as an antiseptic for the preparation of a patient's skin prior to surgery.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CHLORAPREP ONE-STEP FREPP [Chlorhexidine GluconateC22H30Cl2N102C6H12O7 : Isopropyl AlcoholC3H8O]
OTC
-
2% : 70% (1.5ml) (topical sponge)
Becton Dickinson CoApr 26, 2002
  • Use as an antiseptic for the preparation of a patient's skin prior to surgery.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CHLORAPREP ONE-STEP SEPP [Chlorhexidine GluconateC22H30Cl2N102C6H12O7 : Isopropyl AlcoholC3H8O]
OTC
-
2% : 70% (0.67ml) (topical swab)
Becton Dickinson CoOct 7, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CHLORAPREP SINGLE SWABSTICK [Chlorhexidine GluconateC22H30Cl2N102C6H12O7 : Isopropyl AlcoholC3H8O]
OTC
-
2% : 70% (1.75ml) (topical swab)
Becton Dickinson CoMay 10, 2005
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CHLORAPREP TRIPLE SWABSTICK [Chlorhexidine GluconateC22H30Cl2N102C6H12O7 : Isopropyl AlcoholC3H8O]
OTC
-
2% : 70% (5.25ml) (topical swab)
Becton Dickinson CoJun 10, 2009
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CHLORAPREP WITH TINT [Chlorhexidine GluconateC22H30Cl2N102C6H12O7 : Isopropyl AlcoholC3H8O]
OTC
-
2% : 70% (10.5ml) (topical sponge)
2% : 70% (26ml) (topical sponge)
2% : 70% (3ml) (topical sponge)
Becton Dickinson CoApr 3, 2006
  • Use as an antiseptic for the preparation of a patient's skin prior to surgery.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

COMETRIQ [Cabozantinib S-malateC28H24FN3O5C4H6O5]
RX
-
eq 20mg base (oral capsule)
eq 80mg base (oral capsule)
ExelixisNov 29, 2012
  • Method of treating medullary thyroid cancer.
efficacy
5.0  (1)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CRIXIVAN [Indinavir SulfateC36H47N5O4H2O4S]
RX
-
eq 200mg base (oral capsule)
eq 400mg base (oral capsule)
Merck Sharp DohmeMar 13, 1996
  • Treating hiv infection with indinavir sulfate in combination with antiretroviral agents.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DAKLINZA [Daclatasvir DihydrochlorideC40H50N8O62ClH]
RX
-
eq 30mg base (oral tablet)
eq 60mg base (oral tablet)
eq 90mg base (oral tablet)
Bristol-myers SquibbJul 24, 2015
  • Method of inhibiting hepatitis c virus with daklinza and at least one additional compound having anti-hcv activity.
  • Method of inhibiting hepatitis c virus.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DILANTIN [Phenytoin SodiumC15H11N2O2Na]
RX
-
100mg extended (oral capsule)
30mg extended (oral capsule)
Parke-davisApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DILANTIN [PhenytoinC15H12N2O2]
RX
-
50mg (oral tablet, chewable)
PfizerApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DILANTIN-125 [PhenytoinC15H12N2O2]
RX
-
125mg/5ml (oral suspension)
Parke DavisApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIPHENHYDRAMINE HYDROCHLORIDE [Diphenhydramine HydrochlorideC17H21NOClH]
RX
-
12.5mg/5ml (oral elixir)
50mg (oral capsule)
50mg/ml (injection injectable)
Pharm AssocFeb 10, 1982
BarrApproved Prior To Jan 1, 1982
App PharmsMay 28, 2002
HospiraNov 20, 1998
Mylan InstitutionalJul 12, 2005
West-ward Pharms IntApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIPHENHYDRAMINE HYDROCHLORIDE PRESERVATIVE FREE [Diphenhydramine HydrochlorideC17H21NOClH]
RX
-
50mg/ml (injection injectable)
Fresenius Kabi UsaMar 26, 2013
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

DIPYRIDAMOLE [DipyridamoleC24H40N8O4]
RX
-
25mg (oral tablet)
50mg (oral tablet)
5mg/ml (injection injectable)
75mg (oral tablet)
BarrOct 3, 1990
Impax LabsJul 18, 2007
Murty PharmsFeb 13, 2007
Zydus Pharms Usa IncJan 28, 2008
Athenex IncApr 13, 1998
Fresenius Kabi UsaSep 30, 1998
West-ward Pharms IntOct 18, 1996
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EDURANT [Rilpivirine HydrochlorideC22H18N6ClH]
RX
-
eq 25mg base (oral tablet)
Janssen ProdsMay 20, 2011
  • In combination with other antiretroviral agents for the treatment of hiv-1 infection in treatment-naive adult patients with hiv-1 rna less than or equal to 100,000 at the start of therapy.
  • In combination with other antiretroviral agents for the treatment of hiv-1 infection in treatment-naive patients with hiv-1 rna less than or equal to 100,000 at the start of thearpy.
  • In combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-naive adult patients, as set forth in the labeling, including i&u section.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

EXTENDED PHENYTOIN SODIUM [Phenytoin SodiumC15H11N2O2Na]
RX
-
100mg extended (oral capsule)
200mg extended (oral capsule)
300mg extended (oral capsule)
Amneal Pharms NyNov 12, 2008
MylanDec 28, 1998
Sun Pharm Inds (in)Dec 11, 2006
TaroSep 5, 2006
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FACTIVE [Gemifloxacin MesylateC18H20FN5O4CH4O3S]
RX
-
eq 320mg base (oral tablet)
Lg Chem LtdApr 4, 2003
  • Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria.
  • Use of quinolone compounds against anaerobic pathogenic bacteria.
  • Use of quinolone compounds against atypical upper respiratory pathogenic bacteria.
  • Use of quinolone compounds against pneumococcal pathogenic bacteria.
  • Use of quinolone compounds against quinolone-resistant pneumococcal pathogenic bacteria.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FASLODEX [FulvestrantC32H47F5O3S]
RX
-
50mg/ml (intramuscular injectable)
AstrazenecaApr 25, 2002
  • Treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
  • Treatment of hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbococlib in women with disease progression after endocrine therapy.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FOMEPIZOLE [FomepizoleC4H6N2]
RX
-
1.5gm/1.5ml (1gm/ml) (injection injectable)
LuitpoldDec 14, 2007
Mylan InstitutionalMar 3, 2008
Navinta LlcMar 6, 2008
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

FURADANTIN [NitrofurantoinC8H6N4O5]
RX
-
25mg/5ml (oral suspension)
Casper Pharma LlcApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

INJECTAFER [Ferric CarboxymaltoseC18H31O17(C6H10O5)n(Fe)mod(O)mod(HO)modH2O]
RX
-
750mg iron/15ml (50mg iron/ml) (intravenous injectable)
Luitpold Pharms IncJul 25, 2013
  • Method of treatment of iron-related conditions with at least 0.6 grams of elemental iron via an iron carbohydrate complex, with a substantially non-immunogenic carbohydrate component, in about 15 minutes or less..
  • Method of treatment of iron-related conditions with at least 0.6 grams of elemental iron via an iron carbohydrate complex.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

INTELENCE [EtravirineC20H15BrN6O]
RX
-
100mg (oral tablet)
200mg (oral tablet)
25mg (oral tablet)
Janssen R And DJan 18, 2008
  • Combo w/ other antiretrovirals for tx of hiv-1 in antiretroviral tx-experienced pt 6 years up, who have evidence of viral replication and hiv-1 strains resistant to non-nucleoside reverse transcriptase inhibitor and other antiretrovirals.
  • In combination with other antiretroviral agents for the treatment of hiv-1 infection in treatment-experienced adult patients, who have evidence of viral replication and hiv-1 strains resistant to an nnrti and other antiretroviral agents.
  • Treatment of hiv infection in combination with one or more additional hiv antiviral agents.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

INVEGA SUSTENNA [Paliperidone PalmitateC39H57FN4O4]
RX
-
117mg/0.75ml (117mg/0.75ml) (intramuscular suspension, extended release)
156mg/ml (156mg/ml) (intramuscular suspension, extended release)
234mg/1.5ml (156mg/ml) (intramuscular suspension, extended release)
39mg/0.25ml (39mg/0.25ml) (intramuscular suspension, extended release)
78mg/0.5ml (78mg/0.5ml) (intramuscular suspension, extended release)
Janssen PharmsJul 31, 2009
  • Treatment of schizoaffective disorder as a monotherapy and as an adjunct to mood stabilizers or antidepressants.
  • Treatment of schizophrenia.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

JENTADUETO XR [LinagliptinC25H28N8O2 : Metformin HydrochlorideC4H11N5ClH]
RX
-
2.5mg : 1gm (oral tablet, extended release)
Boehringer IngelheimMay 27, 2016
  • Method of treating type 2 diabetes in patients who have not been previously treated with an antihyperglycemic agent by administering linagliptin in combination with metformin.
  • Method of treating type 2 diabetes in patients with insufficient glycemic control despite therapy with one or more conventional antihyperglycemic agents by administering linagliptin in combination with metformin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin and, optionally, a sulfonylurea.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor in combination with metformin.
  • Method of treating type 2 diabetes mellitus by administering a dipeptidyl peptidase-iv inhibitor.
  • Method of treating type 2 diabetes mellitus by administering linagliptin in combination with metformin.
  • Method of treating type 2 diabetes.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

JUBLIA [EfinaconazoleC18H22F2N4O]
RX
-
10% (topical solution)
Dow PharmJun 6, 2014
  • Antimycotic uses, specifically treatment of onychomycosis.
  • Topical treatment of onychomycosis of the toenail(s) due to trichophyton rubrum and trichophyton mentagrophytes.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KALETRA [LopinavirC37H48N4O5 : RitonavirC37H48N6O5S2]
RX
-
100mg : 25mg (oral tablet)
200mg : 50mg (oral tablet)
80mg/ml : 20mg/ml (oral solution)
AbbvieNov 9, 2007
  • Administration without food for treatment of hiv-1 infection.
  • Treatment of hiv-1 infection in combination with other antiretroviral agents.
  • Treatment of hiv-infection in combination with other antiretroviral agents.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LAMICTAL ODT [LamotrigineC9H7Cl2N5]
RX
-
100mg (oral tablet, orally disintegrating)
200mg (oral tablet, orally disintegrating)
25mg (oral tablet, orally disintegrating)
50mg (oral tablet, orally disintegrating)
Glaxosmithkline LlcMay 8, 2009
  • Lamictal is an antiepileptic drug (aed) indicated for: epilepsy-adjunctive therapy in patients greater than or equal to 2 years of age: (1.1) partial seizures primary generalized tonic-clonic seizures.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LONSURF [Tipiracil HydrochlorideC9H11ClN4O2ClH : TrifluridineC10H11F3N2O5]
RX
-
eq 6.14mg base : 15mg (oral tablet)
eq 8.19mg base : 20mg (oral tablet)
Taiho OncologySep 22, 2015
  • Treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-vegf biological therapy, and if ras wild-type, an anti-egfr therapy.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MACRODANTIN [Nitrofurantoin, Macrocrystalline]
RX
-
100mg (oral capsule)
25mg (oral capsule)
50mg (oral capsule)
Alvogen MaltaApproved Prior To Jan 1, 1982
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MARQIBO KIT [Vincristine SulfateC46H56N4O10H2O4S]
RX
-
5mg/5ml (1mg/ml) (intravenous injectable, liposomal)
Talon TherapAug 9, 2012
  • Treatment of adult patients with philadelphia chromosome-negative(ph-) acute lymphoblastic leukemia (all) in second or greater relapse or whose disease has progressed following two or more anti-leukemia therapies.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MECLIZINE HYDROCHLORIDE [Meclizine HydrochlorideC25H27ClN22ClHH2O]
RX
-
12.5mg (oral tablet)
25mg (oral tablet)
Amneal PharmsFeb 23, 2011
Epic Pharma LlcApr 13, 2012
Jubilant CadistaJun 4, 2010
Mylan Pharms IncSep 17, 2012
Par PharmApproved Prior To Jan 1, 1982
SandozMay 22, 1989
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MEMANTINE HYDROCHLORIDE [Memantine HydrochlorideC12H21NClH]
RX
-
10mg (oral tablet)
14mg (oral capsule, extended release)
21mg (oral capsule, extended release)
28mg (oral capsule, extended release)
Ajanta Pharma LtdNov 30, 2015
Alembic Pharms LtdOct 13, 2015
Amneal PharmsApr 10, 2015
Aurobindo Pharma LtdOct 13, 2015
Dr Reddys Labs LtdApr 14, 2010
Jubilant GenericsOct 13, 2015
Lupin LtdApr 10, 2015
Macleods Pharms LtdOct 13, 2015
Mylan Pharms IncJan 30, 2015
Puracap Pharm LlcNov 17, 2015
Silarx Pharms IncNov 10, 2016
Strides PharmaMay 23, 2017
Sun Pharma GlobalMay 5, 2010
Teva PharmsOct 25, 2011
Torrent Pharms LtdOct 13, 2015
Unichem Labs LtdOct 13, 2015
Upsher-smith LabsJul 31, 2015
Wockhardt LtdSep 4, 2015
Zydus Pharms Usa IncJul 10, 2017
Anchen PharmsJun 9, 2017
Apotex IncNov 22, 2016
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.


WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for reference only. Many of these treatments may be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field. The owner of this website will not be held liable for any injuries and deaths cause by following any home remedies. We have no control of what is posted.

Home Remedies for Anti

TOE NAIL FUNGUS [onychomycosis]
   Mix equal parts brown Listerine antiseptic mouth wash and white vinegar. Soak feet in solution for 30 minutes daily until infection is cured.OscarWilde | November 4th, 2017
efficacy
3.8  (5)
side effects
2.0  (2)
danger
1.5  (2)

UNK

CORONAVIRUS [COVID-19]
   Remdesivir is a novel antiviral drug in the class of nucleotide analogs. It was developed by Gilead Sciences as a treatment for Ebola virus disease and Marburg virus infections, though it has subsequently also been found to show antiviral activity against other single stranded RNA viruses such as respiratory syncytial virus, Junin virus, Lassa fever virus, Nipah virus, Hendra virus, and coronaviruses.Jose3124 | February 15th, 2020
efficacy
3.2  (6)
side effects
2.0  (3)
danger
1.5  (2)

UNK

DEPRESSION [major depressive disorder]
   St. John's Wort can be used to relieve anxiety and act as an antidepressant. Take as directed. Approved for as a medicine in Germany. Not recognized in the United States as an effective antidepressant. The plant is poisonous to livestock. Contain a phytochemical chemicals, hyperforin and hypericin, which are make skin sensitive to light with extended use.
Mechanism - Hypericum perforatum
Jlaiii | May 1st, 2020